This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous.Find sources: "Henry Metz" – news · newspapers · books · scholar · JSTOR (April 2019) (Learn how and when to remove this template message) This biographical article is written like a résumé. Please help improve it by revising it to be neutral and encyclopedic. (April 2019) (Learn how and when to remove this template message)

Henry S. Metz is an American pediatric ophthalmologist. He was the CEO of the Smith-Kettlewell Institute in San Francisco from 2003 to 2008. Much of his early research concerned eye movements and strabismus, including saccadic velocity measurements and use of botulinum toxin.

Education and career

After completed his undergraduate degree from Columbia College, Columbia University, Metz received his medical degree from SUNY and MBA from the University of Rochester. He did a medical internship at the Jewish Hospital of Brooklyn, followed by an ophthalmology residency at the University of Rochester School of Medicine and strabismus fellowship at the Smith-Kettlewell Eye Research Institute. His fellowship preceptor was the renowned strabismologist Arthur Jampolsky. During the late 1990s Metz maintained private practice in Rochester and at The Eye Specialists Center in Illinois, and served as Visiting Professor at The University of Illinois Eye and Ear Infirmary until his appointment at Smith-Kettlewell in 2003.

Honors and offices held

Published works (partial list)

See also